Activation of PI3K signaling repressed the induction of MHCI and MHCII in oral carcinoma cells [338], and PI3K inhibition improved MHCI presentation and rendered tumor cells sensitive to recognition by CD8+ T-cells [339]. Here, PIK3CD is linked to lip and oral cavity carcinoma.